These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29846154)

  • 1. An accidental laboratory exposure to
    Wong C; Ng SY; Tan SH
    J Med Microbiol; 2018 Jul; 67(7):1012-1016. PubMed ID: 29846154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A large exposure to Brucella melitensis in a diagnostic laboratory.
    Sam IC; Karunakaran R; Kamarulzaman A; Ponnampalavanar S; Syed Omar SF; Ng KP; Mohd Yusof MY; Hooi PS; Jafar FL; Abubakar S
    J Hosp Infect; 2012 Apr; 80(4):321-5. PubMed ID: 22237130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory exposure to Brucella melitensis in Denmark: a prospective study.
    Knudsen A; Kronborg G; Dahl Knudsen J; Lebech AM
    J Hosp Infect; 2013 Nov; 85(3):237-9. PubMed ID: 24070633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of laboratory-acquired brucellosis.
    Robichaud S; Libman M; Behr M; Rubin E
    Clin Infect Dis; 2004 Jun; 38(12):e119-22. PubMed ID: 15227634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of laboratory-acquired brucellosis: significant side effects of prophylaxis.
    Maley MW; Kociuba K; Chan RC
    Clin Infect Dis; 2006 Feb; 42(3):433-4. PubMed ID: 16392095
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of antibiotic prophylaxis to preventing brucellosis in accidental exposure: A systematic review.
    Nascimento Silva S; Cota G; Souza KM; de Freitas MG; Carvalho JP; Galvão EL
    Trop Med Int Health; 2024 Jun; 29(6):454-465. PubMed ID: 38648858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure of hospital personnel to Brucella melitensis and occurrence of laboratory-acquired disease in an endemic area.
    Yagupsky P; Peled N; Riesenberg K; Banai M
    Scand J Infect Dis; 2000; 32(1):31-5. PubMed ID: 10716074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory exposures to brucella in the UK and Ireland.
    Cooke RP; Chisnall C
    J Hosp Infect; 2012 Nov; 82(3):218. PubMed ID: 22999641
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory-acquired brucellosis--Indiana and Minnesota, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jan; 57(2):39-42. PubMed ID: 18199967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomy of an exposure: a hospital lab's recovery of Brucella melitensis.
    Gannon CK
    MLO Med Lab Obs; 2003 Sep; 35(9):22-5. PubMed ID: 14524145
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid MALDI-TOF-based identification of Brucella melitensis from positive blood culture vials may prevent laboratory-acquired infections.
    Becker SL; Zange S; Brockmeyer M; Grün U; Halfmann A
    J Hosp Infect; 2018 Sep; 100(1):117-119. PubMed ID: 29653133
    [No Abstract]   [Full Text] [Related]  

  • 12. Brucella melitensis: an unexpected isolate from cerebrospinal fluid.
    Wheat PF; Dabbs DJ; Thickett KJ
    Commun Dis Rep CDR Rev; 1995 Mar; 5(4):R56-7. PubMed ID: 7735352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51.
    Ashford DA; di Pietra J; Lingappa J; Woods C; Noll H; Neville B; Weyant R; Bragg SL; Spiegel RA; Tappero J; Perkins BA
    Vaccine; 2004 Sep; 22(25-26):3435-9. PubMed ID: 15308369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human brucellosis in South Africa: Public health and diagnostic pitfalls.
    Wojno JM; Moodley C; Pienaar J; Beylis N; Jacobsz L; Nicol MP; Rossouw J; Bamford C
    S Afr Med J; 2016 Aug; 106(9):883-5. PubMed ID: 27601111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation rates of Brucella melitensis in an endemic area and implications for laboratory safety.
    Shemesh AA; Yagupsky P
    Eur J Clin Microbiol Infect Dis; 2012 Apr; 31(4):441-3. PubMed ID: 21725863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection.
    Atkins HS; Spencer S; Brew SD; Jenner DC; Sefton AM; MacMillan AP; Brooks TJ; Simpson AJ
    Int J Antimicrob Agents; 2010 Jul; 36(1):66-8. PubMed ID: 20022474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brucella melitensis infection following military duty in Iraq.
    Bechtol D; Carpenter LR; Mosites E; Smalley D; Dunn JR
    Zoonoses Public Health; 2011 Nov; 58(7):489-92. PubMed ID: 21824352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic challenges of human brucellosis in Hong Kong: a case series in two regional hospitals.
    Luk S; To WK
    Hong Kong Med J; 2010 Aug; 16(4):299-303. PubMed ID: 20683074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brucella melitensis prosthetic joint infection in a traveller returning to the UK from Thailand: Case report and review of the literature.
    Lewis JM; Folb J; Kalra S; Squire SB; Taegtmeyer M; Beeching NJ
    Travel Med Infect Dis; 2016; 14(5):444-450. PubMed ID: 27591088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staggered enforcement of infection control and prevention measures following four consecutive potential laboratory exposures to imported
    Miendje Deyi VY; Mori M; Dauby N; Clevenbergh P; Mahadeb B; Loizidou A; Maillart E; Martiny D; Debyttere AL; Gerard M; Hallin M
    Infect Prev Pract; 2021 Jun; 3(2):100128. PubMed ID: 34368745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.